These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 37027074)

  • 41. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling human neurodegenerative diseases in transgenic systems.
    Gama Sosa MA; De Gasperi R; Elder GA
    Hum Genet; 2012 Apr; 131(4):535-63. PubMed ID: 22167414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
    Petrucelli L; Dawson TM
    Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cells in animal models of Huntington disease: A systematic review.
    Colpo GD; Furr Stimming E; Teixeira AL
    Mol Cell Neurosci; 2019 Mar; 95():43-50. PubMed ID: 30685323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders.
    Zayed MA; Sultan S; Alsaab HO; Yousof SM; Alrefaei GI; Alsubhi NH; Alkarim S; Al Ghamdi KS; Bagabir SA; Jana A; Alghamdi BS; Atta HM; Ashraf GM
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regenerative medicine improve neurodegenerative diseases.
    Ashraf SS; Hosseinpour Sarmadi V; Larijani G; Naderi Garahgheshlagh S; Ramezani S; Moghadamifar S; Mohebi SL; Brouki Milan P; Haramshahi SMA; Ahmadirad N; Amini N
    Cell Tissue Bank; 2023 Sep; 24(3):639-650. PubMed ID: 36527565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients.
    Duma C; Kopyov O; Kopyov A; Berman M; Lander E; Elam M; Arata M; Weiland D; Cannell R; Caraway C; Berman S; Scord K; Stemler L; Chung K; Khoudari S; McRory R; Duma C; Farmer S; Bravo A; Yassa C; Sanathara A; Singh E; Rapaport B
    Mol Biol Rep; 2019 Oct; 46(5):5257-5272. PubMed ID: 31327120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
    Hasegawa M; Nonaka T; Masuda-Suzukake M
    Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stem cell in neurodegenerative disorders; an emerging strategy.
    Ahani-Nahayati M; Shariati A; Mahmoodi M; Olegovna Zekiy A; Javidi K; Shamlou S; Mousakhani A; Zamani M; Hassanzadeh A
    Int J Dev Neurosci; 2021 Jun; 81(4):291-311. PubMed ID: 33650716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomarkers for Managing Neurodegenerative Diseases.
    Cheslow L; Snook AE; Waldman SA
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
    Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
    PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of molecular chaperone in protein-misfolding brain diseases.
    Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
    Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.